Why Does Liraglutide Work Less Well for Weight Loss After Bariatric Surgery?
Patients with prior metabolic surgery were nearly 7 times less likely to achieve successful weight loss with liraglutide compared to those without surgical history.
Quick Facts
What This Study Found
Prior metabolic surgery was associated with a 6.78x higher odds of poor response to liraglutide for weight loss.
Key Numbers
- 64 adults, BMI 28-32.5, 12-week liraglutide treatment
- Responders: 37 (57.8%); non-responders: 27 (42.2%)
- Responder weight loss: 11.0% (9.04 kg) vs non-responder: 4.2% (3.55 kg)
- Prior metabolic surgery: OR 6.78 for non-response (95% CI 1.95-23.61, p<0.01)
- BMI 30.5+: OR 4.79 for non-response (95% CI 1.46-15.71, p<0.01)
How They Did This
Retrospective analysis of 64 adults with mild obesity on a 12-week liraglutide intervention.
Why This Research Matters
As more patients have histories of both bariatric surgery and GLP-1 medication use, understanding interactions between these approaches is critical for treatment planning.
The Bigger Picture
With the growing overlap between surgical and pharmacological obesity treatments, clinicians need to understand which patients are most likely to benefit from each approach.
What This Study Doesn't Tell Us
Small sample size (64 patients). Retrospective design. Short 12-week duration. No details on type of prior metabolic surgery.
Questions This Raises
- ?What mechanisms explain reduced liraglutide efficacy after bariatric surgery?
- ?Would tirzepatide or semaglutide show similar reduced efficacy in this population?
Trust & Context
- Key Stat:
- 6.78x Higher odds of poor response to liraglutide in patients with prior metabolic surgery
- Evidence Grade:
- Small retrospective study. Low evidence quality but important clinical signal warranting further investigation.
- Study Age:
- Published in 2025.
- Original Title:
- Prior metabolic surgery attenuates the weight-loss efficacy of liraglutide in patients with mild obesity.
- Published In:
- Frontiers in endocrinology, 16, 1580159 (2025)
- Authors:
- Ouyang, Yuqin(2), Xiang, Xinyue(2), Hu, Xinyun, Chu, Xuehui, Tang, Wenjuan, Feng, Wenhuan
- Database ID:
- RPEP-12899
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Frequently Asked Questions
Does prior bariatric surgery affect GLP-1 medication effectiveness?
This study found that patients with prior metabolic surgery were nearly 7 times less likely to achieve successful weight loss with liraglutide.
Should post-surgical patients still try GLP-1 drugs?
They may still benefit, but expectations should be adjusted. Alternative strategies or combination approaches may be more appropriate.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-12899APA
Ouyang, Yuqin; Xiang, Xinyue; Hu, Xinyun; Chu, Xuehui; Tang, Wenjuan; Feng, Wenhuan. (2025). Prior metabolic surgery attenuates the weight-loss efficacy of liraglutide in patients with mild obesity.. Frontiers in endocrinology, 16, 1580159. https://doi.org/10.3389/fendo.2025.1580159
MLA
Ouyang, Yuqin, et al. "Prior metabolic surgery attenuates the weight-loss efficacy of liraglutide in patients with mild obesity.." Frontiers in endocrinology, 2025. https://doi.org/10.3389/fendo.2025.1580159
RethinkPeptides
RethinkPeptides Research Database. "Prior metabolic surgery attenuates the weight-loss efficacy ..." RPEP-12899. Retrieved from https://rethinkpeptides.com/research/ouyang-2025-prior-metabolic-surgery-attenuates
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.